Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of E/C/F/TAF Fixed Dose Combination (FDC) in HIV-1 Infected Adults on Chronic Hemodialysis
Clinical trial NCT02600819 · COMPLETED
Trial details
- NCT number
- NCT02600819
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-14
- Primary completion
- 2017-09-29
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.